 |
Shanghai CAS Intide Biotech Co., Ltd is a joint venture invested by Shanghai CAS Shenglongda Biotech Co., Ltd and Shanghai Institute of Biochemistry and Cell Biology. MEP421 patent in china, America and Britain belongs to the company, which has the right to develop MEP421 into the new medicine. The company registered in Zhangjiang Hi-Tech Park and takes the national preferential policy, devoted to biotech research, production manufacture and distribution.
|
